Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
IL0010941198
Pharmaceuticals
| Market Cap | 1.3B 433M 378M 348M 324M 615M 41.22B 624M 4.18B 1.62B 20.26B 1.63B 1.59B 69.83B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.3B 433M 378M 348M 324M 615M 41.22B 624M 4.18B 1.62B 20.26B 1.63B 1.59B 69.83B | EV / Sales 2026 * |
2.22x | EV / Sales 2027 * | 2.02x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | -0.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -1.28% | - | - | 433M | |
| +4.73% | +3.38% | +19.53% | -8.89% | 66.56B | |
| -1.93% | +0.39% | +58.62% | +226.33% | 56.51B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.98B | |
| +3.45% | +6.04% | -49.46% | -55.91% | 40.46B | |
| +3.04% | +0.04% | +62.66% | -24.29% | 31.91B | |
| +10.01% | +18.57% | +161.59% | -34.48% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +88.24% | 23.35B | |
| +2.87% | +16.83% | +3.78% | +192.67% | 19.46B | |
| -0.13% | +2.75% | +67.48% | +130.07% | 17.18B | |
| Average | +2.53% | +8.76% | +48.56% | +61.76% | 36.67B | |
| Weighted average by Cap. | +2.79% | +7.31% | +43.69% | +54.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 195M 171M 157M 146M 277M 18.57B 281M 1.88B 731M 9.13B 732M 716M 31.46B | 642M 214M 187M 172M 160M 304M 20.39B 309M 2.07B 803M 10.02B 804M 786M 34.53B |
| Net income | 72.01M 24.02M 21M 19.3M 17.99M 34.12M 2.29B 34.64M 232M 90.07M 1.12B 90.17M 88.23M 3.87B | 104M 34.57M 30.22M 27.78M 25.89M 49.11M 3.29B 49.85M 333M 130M 1.62B 130M 127M 5.58B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
